Iovance Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 29.52 M | $80.58 M | 13.72% | 8.11% |
| MHR FUND MANAGEMENT LLC | 02/17/2026 | 28.97 M | $79.08 M | 0.00% | 7.96% |
| VANGUARD GROUP INC | 01/29/2026 | 27.21 M | $74.28 M | 13.08% | 7.47% |
| STATE STREET CORP | 02/13/2026 | 20.16 M | $55.04 M | 51.48% | 5.54% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 14.28 M | $38.98 M | 127.38% | 3.92% |
| INVENOMIC CAPITAL MANAGEMENT LP | 02/17/2026 | 11.96 M | $32.65 M | 13.45% | 3.29% |
| MORGAN STANLEY | 02/13/2026 | 9.19 M | $25.09 M | 64.68% | 2.53% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 8.61 M | $23.50 M | 30.90% | 2.36% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 02/17/2026 | 8.60 M | $23.48 M | -5.67% | 2.36% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 7.99 M | $21.82 M | 16.36% | 2.20% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 7.12 M | $19.43 M | -6.58% | 1.95% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 6.59 M | $17.98 M | 49.22% | 1.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 4.95 M | $13.51 M | 49.66% | 1.36% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 4.40 M | $12.01 M | 60.46% | 1.21% |
| HRT FINANCIAL LP | 02/12/2026 | 4.36 M | $11.89 M | 1,078.27% | 1.20% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 3.83 M | $10.46 M | 4,925.38% | 1.05% |
| JANE STREET GROUP, LLC | 02/12/2026 | 3.58 M | $9.78 M | 153.51% | 0.98% |
| CITADEL ADVISORS LLC | 02/17/2026 | 3.14 M | $8.58 M | -17.73% | 0.86% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 3.02 M | $8.23 M | 184.70% | 0.83% |
| JPMORGAN CHASE & CO | 02/11/2026 | 3.00 M | $8.19 M | 145.25% | 0.82% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 2.75 M | $7.52 M | 9.93% | 0.76% |
| NORTHERN TRUST CORP | 02/17/2026 | 2.58 M | $7.04 M | 4.82% | 0.71% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 1.99 M | $5.44 M | 31.37% | 0.55% |
| ORION INVESTMENT CO | 02/11/2026 | 1.86 M | $5.07 M | 0.28% | 0.51% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.69 M | $4.62 M | 17.83% | 0.46% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2026 | 1.60 M | $4.36 M | 45.32% | 0.44% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.54 M | $4.20 M | -45.48% | 0.42% |
| B GROUP, INC. | 02/17/2026 | 1.50 M | $4.10 M | 0.00% | 0.41% |
| RICE HALL JAMES & ASSOCIATES, LLC | 02/17/2026 | 1.43 M | $3.89 M | -1.81% | 0.39% |
| NUVEEN, LLC | 02/12/2026 | 1.39 M | $3.78 M | 10.75% | 0.38% |
| C WORLDWIDE GROUP HOLDING A/S | 02/04/2026 | 1.26 M | $3.44 M | 0.00% | 0.35% |
| INVESCO LTD. | 02/19/2026 | 1.25 M | $3.42 M | 32.39% | 0.34% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.19 M | $3.26 M | -42.09% | 0.33% |
| BARCLAYS PLC | 02/13/2026 | 1.13 M | $3.08 M | 20.33% | 0.31% |
| MIRADOR CAPITAL PARTNERS LP | 01/14/2026 | 1.03 M | $2.82 M | 100.87% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 955.47 K | $2.61 M | 18.37% | 0.26% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 02/17/2026 | 914.45 K | $2.50 M | 0.26% | 0.25% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 872.99 K | $2.38 M | 1,001.95% | 0.24% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 822.75 K | $2.25 M | 2,143.24% | 0.23% |
| UBS GROUP AG | 01/29/2026 | 764.15 K | $2.09 M | -18.40% | 0.21% |
| ABRDN PLC | 01/16/2026 | 759.52 K | $2.07 M | 25.08% | 0.21% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/13/2026 | 706.45 K | $1.93 M | 46.27% | 0.19% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 690.42 K | $1.88 M | 6.97% | 0.19% |
| QVT FINANCIAL LP | 02/13/2026 | 678.56 K | $1.85 M | 0.00% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 659.40 K | $1.80 M | -28.34% | 0.18% |
| CITADEL ADVISORS LLC | 02/17/2026 | 658.20 K | $1.80 M | 1.70% | 0.18% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 651.00 K | $1.78 M | 100.00% | 0.18% |
| VOLEON CAPITAL MANAGEMENT LP | 02/17/2026 | 630.26 K | $1.72 M | 350.28% | 0.17% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 02/13/2026 | 628.54 K | $1.72 M | 379.80% | 0.17% |
| LPL FINANCIAL LLC | 02/11/2026 | 623.07 K | $1.70 M | 1.91% | 0.17% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Iovance Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 388 institutional investors and hedge funds held shares of Iovance Biotherapeutics Inc. The most heavily invested institutionals were:
JANE STREET GROUP, LLC: 4.17 M
Nuveen, LLC: 3.66 M
DIMENSIONAL FUND ADVISORS LP: 2.65 M
VANGUARD FIDUCIARY TRUST CO: 2.18 M
WELLS FARGO & COMPANY/MN: 2.07 M
Orion Investment Co: 2.07 M
71.86% of Iovance Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 311.49 M shares in the last 24 months. This purchase volume represents approximately $1.69 B in transactions.